On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

IGM Biosciences (United States)

InstitutionResearch output, impact & collaborations

IGM Biosciences (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about IGM Biosciences (United States)?

ScholarIQrecord summary

IGM Biosciences (United States) is a research organisation in Mountain View, US. OpenAlex records 126 works and 15,504 citations for it. 122 researchers list it as their most recent affiliation.

How many works does IGM Biosciences (United States) have?

ScholarIQindexed works

IGM Biosciences (United States) has 126 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for IGM Biosciences (United States) →

How many citations does IGM Biosciences (United States) have?

ScholarIQcitation count

IGM Biosciences (United States) has 15,504 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for IGM Biosciences (United States) →

How many researchers are at IGM Biosciences (United States)?

ScholarIQresearcher count

IGM Biosciences (United States) has 122 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at IGM Biosciences (United States)?

ScholarIQavg h-index

IGM Biosciences (United States) has an average h-index of 44.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of IGM Biosciences (United States)?

ScholarIQror

The ROR for IGM Biosciences (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for IGM Biosciences (United States)?

ScholarIQopenalex

The OpenAlex for IGM Biosciences (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind IGM Biosciences (United States)?

ScholarIQtop researchers by citations

Roel Funke · Cancer Immunotherapy and Biomarkers

66 works32,891 citations

John W. Shiver · HIV Research and Treatment

153 works16,524 citations

What are the most-cited papers on IGM Biosciences (United States)?

ScholarIQmost cited works

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults

Frances Priddy, Deborah D. Brown, James G. Kublin, Kathleen Monahan, David P. Wright, Jacob Lalezari, Steven Santiago, Michael Marmor, Michelle Lally, Richard M. Novak, Stephen J. Brown, P.P. Kulkarni, Sheri Dubey, Lisa Kierstead, Danilo R. Casimiro, Robin Mogg, Mark J. DiNubile, John W. Shiver, Randi Y. Leavitt, Michael Robertson, Devan V. Mehrotra, Erin Quirk, Merck V520‐016 Study Group

Clinical Infectious Diseases. 2008248 CitationsOPEN ACCESS

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)

Marcin Kowanetz, Wei Zou, Scott Gettinger, Hartmut Koeppen, Mark Kockx, Peter Schmid, Edward E. Kadel, Ignacio I. Wistuba, Jamie E. Chaft, Naiyer A. Rizvi, David R. Spigel, Alexander I. Spira, Fred R. Hirsch, Victor Cohen, Dustin Smith, Zach Boyd, Natasha Miley, Susan Flynn, Vincent Lévêque, David S. Shames, Marcus Ballinger, Simonetta Mocci, Geetha Shankar, Roel Funke, Garret M. Hampton, Alan Sandler, Lukas C. Amler, Ira Mellman, Daniel S. Chen, Priti S. Hegde

Proceedings of the National Academy of Sciences. 2018240 CitationsOPEN ACCESS

How much of the research on IGM Biosciences (United States) is open access?

ScholarIQopen access share

100%OPEN ACCESS

Gold

Green

Hybrid

Bronze

100%

Closed